Skip to main content
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2008 Aug 22;13(8b):1775–1783. doi: 10.1111/j.1582-4934.2008.00480.x

Functional linkage of Na+‐Ca2+‐exchanger to sarco/endoplasmic reticulum Ca2+ pump in coronary artery: comparison of smooth muscle and endothelial cells

Kim A Davis 1, Sue E Samson 2, Kaitlin E Hammel 2, Lorand Kiss 3, Ferenc Fulop 3, Ashok K Grover 1,2,
PMCID: PMC6512390  PMID: 18752635

Abstract

An increase in cytosolic Ca2+ concentration in coronary artery smooth muscle causes a contraction but in endothelium it causes relaxation. Na+‐Ca2+‐exchanger (NCX) may play a role in Ca2+ dynamics in both the cell types. Here, the NCX‐mediated 45Ca2+ uptake was compared in Na+‐loaded pig coronary artery smooth muscle and endothelial cells. In both the cell types, this uptake was inhibited by KB‐R7943, SEA 0400 and by monensin, but not by cariporide. Prior loading of the cells with the Ca2+ chelator BAPTA increased the NCX‐mediated 45Ca2+ uptake in smooth muscle but not in endothelial cells. In the presence or absence of BAPTA loading, the Na+‐mediated 45Ca2+ uptake was greater in endothelial than in smooth muscle cells. In smooth muscle cells without BAPTA loading, thapsigargin diminished the NCX‐mediated 45Ca2+ entry. This effect was not observed in endothelial cells or in either cell type after BAPTA loading. The results in the smooth muscle cells are consistent with a limited diffusional space model in which the NCX‐mediated 45Ca2+ uptake was enhanced by chelation of cytosolic Ca2+ or by its sequestration by the sarco/endoplasmic reticulum Ca2+ pump (SERCA). They suggest a functional linkage between NCX and SERCA in the smooth muscle but not in the endothelial cells. The concept of a linkage between NCX and SERCA in smooth muscle was also confirmed by similar distribution of NCX and SERCA2 proteins when detergent‐treated microsomes were fractionated by flotation on sucrose density gradients. Thus, the coronary artery smooth muscle and endothelial cells differ not only in the relative activities of NCX but also in its functional linkage to SERCA.

Keywords: NCX, SERCA, coupling, lipid rafts, BAPTA, thapsigargin

Introduction

The increase in cytosolic Ca2+ ([Ca2+]i) occurs by activation of extracellular Ca2+ entry via Ca2+ channels and Na+‐Ca2+‐exchanger (NCX, 3Na+: 1Ca2+), and by Ca2+ release from intracellular sources [1, 2, 3, 4]. The main pathways to lower [Ca2+]i are the sarco/endoplasmic reticulum (SER) Ca2+ pump (SERCA), plasma membrane Ca2+ pump (PMCA) and NCX [2, 3, 4, 5, 6, 7]. SERCA pumps have high affinity for Ca2+ and can sequester it into the SER [6, 7, 8]. PMCA extrude Ca2+ from cells with a high affinity [9, 10, 11]. NCX has a lower affinity for Ca2+ and is often referred to as a high capacity low affinity Ca2+ mobilizing system [4, 8, 12, 13]. KNCX that exchange 4 Na+ for 1 Ca2++ 1 K+ have also been reported [14]. NCX (and KNCX) is non‐vectorial and depending on Na+ and Ca2+ electrochemical gradients, it may expel Ca2+ from cells (forward mode) or allow its entry (reverse mode). NCX are encoded by three genes: NCX1, 2 and 3. NCX1 is expressed in most tissues, NCX2 in many tissues, and NCX3 mainly in skeletal muscle and brain [3, 4, 15]. Various NCX gene products perform similar functions but may differ in their regulation.

Coronary tone is regulated by changes in [Ca2+]i. In coronary artery, an increased [Ca2+]i in smooth muscle cells (SMC) causes a contraction but an increase in [Ca2+]i in the endothelial cells (EC) may cause relaxation. Expression and function of PMCA and SERCA in the coronary artery SMC and EC are well documented [16, 17, 18]. SMC express PMCA isoforms 1 and 4 and the SERCA isoform 2b. Coronary artery EC express much lower levels of PMCA1, and very low levels of SERCA2b and SERCA3 [16, 18]. Based on RT‐PCR experiments, the coronary artery SMC and EC express mRNA for NCX1: mainly the splice variant NCX1.3 and smaller amounts of NCX1.7 [16]. This is in contrast to cardiac myocytes, which express mainly NCX1.1 [3, 4, 15]. The expression of mRNA for the NCX regulatory protein phospholemman occurs in coronary artery SMC but not in EC [16, 19, 20, 21, 22]. Based on determination of changes in the [Ca2+]i levels, it has been suggested that NCX plays a role in smooth muscle contractility [12, 13, 23, 24, 25, 26, 27, 28, 29, 30]. Results of some of these experiments are ambiguous since the actual Ca2+ movement was not examined. Here, we compare properties of NCX‐mediated 45Ca2+ uptake in Na+‐loaded SMC and EC. We show that in SMC there is a functional and possibly a spatial linkage between NCX and SERCA. The functional linkage was not observed in EC.

Methods

Cell cultures

Pig coronary artery SMC and EC were cultured as previously described [31]. Confluent SMC cultures from passage 3 were divided, cultured again and used on day 7 of growth and cells from passage 4 were split for EC. The cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with: 0.5 mM 4‐(2‐hydroxyethyl‐1‐piperazine ethane sulfonate) (HEPES) pH 7.4, glutamine (2 mM), gentamicin (50 mg/l), amphotericin B (0.125 mg/l) and 10% foetal bovine serum.

45Ca2+‐uptake measurement

Cells in 60 mm plates were washed twice in the MOPS (3‐(N‐Morpholino)‐propanesulfonic acid) buffer (in mM: 20 MOPS, 140 NaCl, 2 MgCl2‐, pH 7.4 at 37°C and 10 μM nitrendipine) and then Na+‐loaded in the MOPS buffer containing 1 mM ouabain, 25 μM nystatin and 10 μM nitrendipine for 20 min. at 37°C with gentle shaking. The cells were then quickly washed twice in 2 ml of the above mentioned MOPS buffer with only nitrendipine and then placed in 45Ca2+ solutions at pH 7.4 at 37°C with either 130 mM Na+ or 130 NMG+ (N‐methylglucamine‐HCl, pH 7.4 at 37°C for Na+ substitution) with various additives. The cells were washed 6 times with ice‐cold MOPS‐tris (pH 7.4 determined at 37°C) with MgCl2‐ and LaCl3‐ to remove extracellular radioactivity. One millilitre of cold 0.1% Triton X‐100 with 1 mM EGTA (ethyleneglycol bis(b‐aminoethyl ether)‐N,N,N’,N’‐tetraacetic acid) was added to each plate. The cells were then scraped, placed into scintillation vials; 100 μl of the suspension was saved for protein estimation and the remainder used for scintillation counting. In some experiments, the cells were loaded with BAPTA prior to Na+‐loading. BAPTA/AM (20 μM, 1,2‐bis(2‐aminophenoxy)ethane‐N,N,N’,N’‐tetraacetic acid tetrakis(acetoxymethyl ester)), was added to cells in the culture medium and placed for 2 hrs in the incubator at 37°C. The cells were then Na+‐loaded and used as before. Any other inhibitors were included only in the 45Ca2+ accumulation solution at specified concentrations. When the additives were dissolved in solvents other than water, the solvents were also used in the vehicle controls.

Subfractionation of detergent‐treated microsomes and Western blots

Smooth muscle from coronary arteries of 60 pig hearts (Maple Leaf Meats, Burlington, Canada) was dissected and used for isolating microsomes as described previously [32]. The microsomes were washed two times in 8% sucrose (weight/weight) and 25 mM HEPES (N‐2‐hydroxyethylpiperazine‐N’‐2‐ethanesulfonic acid) buffer at pH 7.0 and then suspended in 300 μl of the same solution. The microsomal suspension was mixed with 60 μl of 1 M NaCl and 40 μl of 10% Triton X‐100. The suspension was kept on ice with occasional mixing for 15 min. after which 800 μl of 60% sucrose (w/w) was added to obtain a uniform mixture [33]. This suspension (600 μl) was pipetted into the bottom of a centrifuge tube for TLS‐55 rotor and different concentrations of sucrose were layered on the top. The tubes were centrifuged at 160,000 g for 20 hrs at 4°C. Fractions (230 μl) were collected from the top, aliquoted and saved at −20°C for the analysis.

The primary antibodies were purchased from the following sources: anti‐SERCA antibody IID8 (Affinity Bioreagents, Golden, MO, USA), anti‐NCX1 antibody R3F1 (Swant Swiss Antibodies, Bellinzona, Switzerland), anti‐caveolin‐1 and anti‐flotillin‐2/ESA (BD Biosciences, Mississuaga, Canada), anti‐prion protein antibody 6H4 (Prionics AG, Switzerland). Western blots were treated with the primary antibodies and horseradish peroxidase conjugated anti‐mouse IgG (GE Healthcare, Baie d’Urfe, QC, Canada) at a 20,000× dilution was used. The peroxidase activity was visualized with a femto‐kit (Pierce Chemical Company, Rockford, IL, USA) and a LAS3000 mini Luminiscent Image Analyzer (Fujifilm Life Science, Stamford, CT, USA). Ganglioside GM were detected in dot blots using horseradish peroxidase conjugated cholera toxin B subunit (Calbiochem, San Diego, CA, USA). Cholesterol determination was carried out using an Amplex red kit following instructions of the manufacturer (Invitrogen, Burlington, Canada).

Data analysis

Values presented are mean ± S.E.M. of the specified number of replicates. Student’s t‐test was used to test null hypotheses and P‐values < 0.05 were considered to negate them. The results were also verified with a one‐way ANOVA test. Each experiment was repeated two to four times with the specified number of replicates per experiment.

Results

In Western blots, the SMC reacted positively with anti‐smooth muscle α‐actin and SERCA2b‐selective antibody, IID8, but not with selective antibodies against SERCA2a, endothelial NO synthase (eNOS) or von Willebrand factor as described previously [31, 34]. In Western blots, the EC reacted positively with antibodies against eNOS or von Willebrand factor as described previously and negatively with anti‐smooth muscle α‐actin [31, 34].

Time course of NCX‐mediated 45Ca2+‐entry

Na+‐loaded SMC were incubated in media containing extracellular Na+ or NMG+ to examine the accumulation of 45Ca2+. Difference between uptake in the two solutions was defined as the NCX‐mediated uptake. In an initial experiment, we observed that the value of the NCX‐mediated uptake was very small compared to the uptake in the Na+‐containing solution (Fig. 1). Therefore, we considered preloading the cells with the Ca2+‐chelator BAPTA to increase the NCX‐mediated accumulation of 45Ca2+. SMC were preloaded with BAPTA for 2 hrs prior to Na+‐loading and then used to examine the uptake. Preloading with BAPTA caused an increase in the NCX‐mediated 45Ca2+‐uptake (Fig. 1). Thus, lowering [Ca2+]i with BAPTA caused an increase in the NCX‐mediated 45Ca2+‐uptake.

Figure 1.

Figure 1

Effect of BAPTA on the NCX‐mediated 45Ca2+‐uptake in SMC. Ca2+ uptake was carried out using Na+‐loaded cells in media containing extracellular Na+ or NMG+. NCX‐mediated Ca2+ uptake is the difference between the two groups. The data were normalized to total cell protein. Analysis by anova followed by Tukey–Kramer multiple comparison test showed that the NCX‐dependent Ca2+ uptake was greater in the BAPTA‐loaded cells at 1 min. (P < 0.05, q = 4.681) and 5 min. (P < 0.05, q = 4.371) than in the cells without BAPTA loading (P < 0.05, F = 22.982, df = 17).

Time course of the NCX‐mediated 45Ca2+‐uptake in Na+‐and BAPTA‐loaded SMC and EC is in Fig. 2. 45Ca2+‐accumulation in Na+‐ and BAPTA‐loaded cells in Na+‐containing and NMG+‐containing solutions are shown. The difference between the uptake in the two solutions is shown as NCX in the insets. The slope of the NCX‐mediated 45Ca2+‐accumulation over 5 min. did not differ significantly from that over 2 min. (P > 0.05) but the slope in 5–10 min. was significantly smaller (P < 0.05). Thus, in both SMC and EC, the NCX‐mediated component of the uptake was linear with time for up to 5 min. Hence the uptake in 5 min. was examined in the subsequent experiments.

Figure 2.

Figure 2

Time course of the NCX‐mediated 45Ca2+‐uptake in BAPTA‐loaded SMC and EC. The cells were loaded with BAPTA and then with Na+ and then 45Ca2+‐uptake was examined in solutions containing Na+ or NMG+. The difference in the uptake between the two solutions is shown in the insets as NCX. The data are mean ± S.E.M. of 6 replicates for each time point. The slope of the NCX‐mediated 45Ca2+‐uptake over 5 min. did not differ significantly from the slope over 2 min. (P > 0.05), but the slope in 5–10 min. was significantly smaller (P < 0.05).

The 45Ca2+‐accumulation in Na+‐ and BAPTA‐loaded cells in NMG+‐containing solutions and in those containing NMG+ plus K+ was compared to determine if there was any KNCX‐activity (Table 1). The values of the uptake in the two solutions did not differ significantly indicating that there was no detectable component of the KNCX‐mediated 45Ca2+‐accumulation. This experiment was repeated several times with and without BAPTA loading (not shown) but there was no detectable KNCX.

Table 1.

KNCX‐mediated 45Ca2+‐uptake in SMC and EC

45 Ca 2+‐uptake (nmol/mg protein)
SMC EC
NMG+ 0.95 ± 0.11 5.05 ± 0.08
K+ plus NMG+ 0.90 ± 0.09 5.12 ± 0.13
KNCX 0.06 0.08

Note: For 45Ca2+‐uptake, the Na+‐and BAPTA‐loaded SMC or EC were incubated in a solution containing NMG+ alone or NMG+ plus K+ for 5 min. The data are mean ± S.E.M. of 6 replicates. The presence of K+ did not alter the magnitude of the 45Ca2+‐accumulation in SMC or EC (P > 0.05).

Effects of NCX inhibitors on the NCX‐mediated 45Ca2+‐uptake

We had defined the NCX‐mediated 45Ca2+ uptake by Na+‐loaded SMC and EC simply as the difference between the values in the Na+ and NMG+‐containing solutions. To validate this definition, we used several inhibitors (Table 2). The NCX inhibitors KB‐R7943 and SEA 0400 caused nearly complete inhibition of the NCX‐mediated uptake. Since the NCX activity depends on the Na+‐gradient across the plasma membrane (PM), the Na+ ionophore monensin is expected to collapse this gradient and hence inhibit the NCX‐mediated uptake. Monensin inhibited the NCX‐mediated uptake in both SMC and EC. Low extracellular or high intracellular Na+‐concentrations may also inhibit the Na+‐H+‐exchanger. Therefore, we also tested the effects of the Na+‐H+‐exchanger inhibitor cariporide. Cariporide had no effect on the NCX‐mediated uptake in SMC or EC. Together, the use of these inhibitors validated our method to monitor the NCX‐mediated 45Ca2+ uptake.

Table 2.

Inhibition of the NCX‐mediated 45Ca2+‐uptake in SMC and EC

SMC Percentage inhibition
EC
KB‐R7943
 3 μM 56 ± 10 48 ± 10
 10 μM 65 ± 10 67 ± 3
 30 μM 91 ± 6 99 ± 2
SEA 0400
 0.3 μM 66 ± 5 92 ± 1
 3 μM 100 ± 5 98 ± 2
Monensin
 20 μM 74 ± 8 91 ± 6
Cariporide
 2 μM −8 ± 14 1 ± 12
10 μM 0 ± 8 −5 ± 14

Note: The NCX‐mediated component was computed as the difference between the uptake in solutions with Na+ or NMG+. The inhibitors were included in the 45Ca2+‐uptake solutions. The experiments with each inhibitor were conducted on separate days. In each experiment, the value at each concentration of the inhibitor was computed as percentage of the mean value in the absence of the inhibitor. Values in each experiment are mean ± S.E.M. from 6 to 12 replicates. KB‐R7943, SEA 0400 and monensin caused significant inhibition (P < 0.05) at the concentrations used but cariporide did not cause a significant inhibition (P > 0.05). The experiments with each inhibitor were repeated three times and similar results were obtained.

Comparing NCX‐mediated 45Ca2+‐uptake and the effect of BAPTA in SMC and EC

Two major observations emerged upon comparing the NCX‐mediated 45Ca2+‐uptake in SMC and EC. The first observation was that SMC and EC differed in the effects of BAPTA loading. In three paired experiments, the NCX‐mediated uptake was compared in SMC with and without BAPTA loading. Each time, the BAPTA‐loaded cells showed greater NCX‐mediated uptake (data not shown). In comparison, BAPTA caused a marginal but not significant increase in EC (P > 0.05). This discrepancy cannot be attributed to an inability of EC to absorb BAPTA‐AM and digest it since they have been shown to respond to BAPTA loading in ascorbate release experiments [34]. The values of the NCX‐mediated 45Ca2+‐uptake were also compared in several unpaired experiments conducted on different days (Fig. 3). The NCX‐mediated uptake was 0.71 ± 08 nmol/mg protein in 15 experiments using SMC with no BAPTA loading and 1.95 ± 08 nmol/mg protein in 16 experiments using BAPTA‐loaded SMC. Thus BAPTA loading caused a significant increase in the NCX‐mediated uptake in SMC. An increase was not observed in EC in similar unpaired experiments. The second observation was that the NCX‐mediated 45Ca2+‐uptake was significantly greater in EC than in SMC, with or without BAPTA loading (Fig. 3).

Figure 3.

Figure 3

Comparison of the NCX‐mediated 45Ca2+‐uptake in SMC and EC in 5 min. with and without BAPTA loading. The mean value of the NCX‐mediated 45Ca2+‐uptake from 5 to 6 replicates on a single day was taken as one replicate. The values are mean ± S.E.M. from 15 experiments for group A (SMC without BAPTA loading), 7 for group B (EC without BAPTA loading), 17 for group C (SMC with BAPTA loading) and 15 for group D (EC with BAPTA loading). One way anova followed by a multiple comparison with Tukey–Kramer test showed that there were significant differences between groups A and B (Q = 5.885, P < 0.001), A and C (Q = 2.305, P < 0.05), C and D (Q = 6.959, P < 0.001) but not B and D (Q = 0.6919, P > 0.05).

Comparing the effect of thapsigargin on NCX‐mediated 45Ca2+‐uptake in SMC and EC

We examined the effects of thapsigargin on the NCX‐mediated 45Ca2+‐uptake by SMC and EC with and without BAPTA loading (Fig. 4). In each of the 5 experiments, when SMC were not BAPTA‐loaded, the addition of 1 μM thapsigargin to the uptake solution decreased the NCX‐mediated 45Ca2+‐uptake. This inhibition was 65 ± 10% in the 5 experiments (Fig. 4). However, thapsigargin did not cause a significant inhibition in the NCX‐mediated uptake when BAPTA loaded SMC were used. In EC, it caused a small but statistically insignificant decrease in the NCX‐mediated uptake with or without BAPTA loading (Fig. 4).

Figure 4.

Figure 4

Thapsigargin inhibition of the NCX‐mediated 45Ca2+‐uptake in SMC and EC in 5 min. with and without BAPTA loading. The mean value of the inhibition from 5 to 6 replicates on a single day was taken as one replicate. The values are mean ± S.E.M. of the uptake from 8 days for group A (SMC without BAPTA loading), 6 days for group B (EC without BAPTA loading), 3 days for group C (SMC with BAPTA loading), and 3 days for group D (EC with BAPTA loading). One way anova followed by a multiple comparison with Tukey–Kramer test showed that there were significant differences between groups A and B (Q = 5.014, P < 0.05), A and C (Q = 5.284, P < 0.01) but not for B and D (Q = 1.072, P > 0.05) or C and D (Q = 0.1368, P > 0.05).

NCX and SERCA2 distribution in detergent‐treated smooth muscle microsomes

Since there was evidence for a functional linkage between NCX and SERCA in SMC, an experiment was conducted to search for a potential spatial linkage. Microsomal membranes from the smooth muscle tissue of pig coronary artery were treated with Triton X‐100 and subjected to isopycnic centrifugal flotation on a sucrose density gradient. The distribution of NCX, SERCA2 and several markers was examined (Fig. 5). The fractions with the lowest density had the highest cholesterol to protein ratio and those with the highest density were poor in cholesterol. The distribution for caveolin and the lipid raft markers ganglioside GM1, flotillin and prion proteins were also shown in Fig. 5. Quantification and further analysis of the various markers showed that their distributions were similar but not identical to that of cholesterol. The values of the correlation coefficient (r2) for these markers were flotillin (0.8929), ganglioside GM1 (0.8399), prion protein (0.7175) and caveolin (0.5650). A major band at the expected molecular weight was obtained for NCX (116 kD) and for SERCA2 (110 kD). The distributions of NCX and SERCA2 correlated with each other with an r2 value of 0.5249 (P= 0.0077). Repeating this experiment also gave similar distribution for NCX and SERCA2. Thus, there may be a spatial co‐localization of NCX and SERCA2 in the pig coronary artery smooth muscle. The distributions of NCX (r2= 0.3745, P= 0.0344) and SERCA2 (r2= 0.8233, P < 0.0001) also correlated significantly with the caveolin distribution.

Figure 5.

Figure 5

Distribution of NCX and SERCA2 in fractions obtained from isopycnic flotation of the detergent‐treated microsomes obtained from the coronary artery smooth muscle tissue. Fraction numbers are given on the top. Locations of protein markers with molecular weights in kD are shown on the right. In each lane, 2 μg protein (5 μg for NCX1) of the specified fraction 1–12 was used for Western blots. Flot. = flotillin, PrP = prion protein, Gang. = ganglioside. Ganglioside amounts were determined in dot blots using 1 μg protein/fraction. The graph shows protein and cholesterol amounts and sucrose gradients in these fractions. Relative amounts of protein concentration/fraction were determined taking the value in fraction 12 as 100%. Relative amounts of cholesterol/μg protein were determined taking the value in fraction 1 as 100%.

It would have been ideal to conduct a similar experiment to test for a linkage between NCX and SERCA in EC. However, the abundance of SERCA protein in EC is very low [16]. Therefore, this experiment is not feasible.

Discussion

The results indicated that the NCX‐mediated Ca2+ entry was greater in EC than in SMC and that this entry was increased by BAPTA loading only in SMC. Thapsigargin inhibited this NCX activity in SMC not loaded with BAPTA. NCX and SERCA2 showed similar distribution upon isopycnic flotation of detergent‐treated microsomes from SMC. The Discussion will focus on the validity of the methods, comparison of these observations with the literature, and potential physiological and pathophysiological implications of the results.

Validation of the methods used

NCX‐mediated Ca2+ entry in vascular smooth muscle has been examined in the literature using electrophysiology, monitoring [Ca2+]i using fluorescence probes, examination of vascular contractility or as 45Ca2+ uptake in Na+‐loaded cells [2, 13, 23, 25, 26, 27, 29, 35, 36]. Each method has its own advantages and pitfalls. Here, we examined the NCX‐mediated 45Ca2+ uptake in the Na+‐loaded SMC and EC. The main advantage of this method is that it gives a direct measure of the 45Ca2+ taken up by the cells. One of its pitfalls is that it does not distinguish between 45Ca2+43Ca2+ exchange and the actual 45Ca2+ entry. However, this hurdle was overcome pharmacologically. The NCX‐mediated 45Ca2+ uptake in the Na+‐loaded cells was defined as the difference in the uptake between the cells placed in solutions that contained Na+ or those in which Na+ was substituted with NMG+. This component of the uptake was inhibited nearly completely in both SMC and EC by the NCX inhibitors KB‐R7943 and SEA 0400 [37, 38, 39]. KB‐R7943 may also inhibit L‐type VOCC but this was not an issue since the uptake solutions contained 10 μM nitrendipine, which is in excess of the nanomolar concentrations needed to block the L‐type VOCC. The inhibition of Ca2+ uptake with SEA 0400, which is more selective for NCX than KB‐R7943, further validates the role of NCX. It is also pointed out that SEA 0400 is more selective for NCX1, which is the NCX isoform expressed in SMC and EC [16, 37]. The inhibition with the Na+‐ionophore monensin established the need for a Na+‐gradient. However, alterations in Na+‐gradients may also alter the Na+‐pump activity but this possibility was eliminated using ouabain. The possibility that the observed activity of NCX was due to Na+‐ H+‐exchanger was eliminated since cariporide did not have any effect. Although these experiments validated the definition of the NCX‐mediated Ca2+ entry used in this work the possibility of a partial contribution of passive entry via unspecified Ca2+ channels cannot be completely ruled out.

Linkage between NCX and SERCA in SMC

Loading SMC with BAPTA increased the NCX‐mediated Ca2+ uptake. Thapsigargin inhibited the uptake when they were not loaded with BAPTA but it had no significant effect when they were loaded with BAPTA. These results are consistent with a hypothesis of a functional linkage between NCX and SERCA: Ca2+ that enters via NCX can be sequestered into SER by SERCA [25]. The inhibition of SERCA would block this pathway and decrease the entry. Chelation of the entered Ca2+ by BAPTA would allow for maintenance of the Ca2+ gradient and hence eliminate the need for the functional linkage with the SERCA pump. However, one cannot rule out the possibility that thapsigargin may open store depletion‐dependent cation channels which are less selective for Ca2+ and may play a role [1, 36].

NCX and SERCA2 showed similar distribution when the Triton X‐100‐treated smooth muscle microsomes were fractionated by density gradient flotation. Caveolae are specialized lipid raft rich membranes containing the protein caveolin [23, 33, 40, 41, 42]. Centrifugation of non‐ionic detergent‐treated membranes have been used to separate lipid raft rich PM from other membranes with and without caveolin [33, 43]. However, the distributions of various lipid raft markers were similar but not identical to that of cholesterol with the cholesterol to caveolin distribution correlation being the weakest. These correlations are consistent with the lipid raft membrane being heterogenous and only part of it forming caveolae. The correlation between the distributions of NCX and SERCA2 in these fractions was statistically significant. These distributions also correlated significantly with that of caveolin. The data are consistent with a spatial linkage between SERCA2, caveolin and NCX in a model proposed based on electron microscopy studies [13]. Literature has also used high pH treatment along with sonication for similar membrane fractionation [44, 45, 46]. In preliminary experiments, this treatment was shown to cause oligomerization of the SERCA2 protein (data not shown). SERCA2 protein has also been shown to be polymerized by reactive oxygen species [47].

Although this is the first report on a functional and possibly a spatial linkage between NCX and SERCA in coronary artery SMC, the literature on various tissues supports this concept [1, 2, 12, 13, 23, 25, 26, 27, 36, 40, 41, 42]. The actions of NCX and SERCA have been proposed to be linked through a limited junctional cytoplasmic space model [13, 25, 26, 27]. Immunofluorescence studies on cultured arterial myocytes suggest that the exchanger molecules are organized in reticular patterns over the cell surfaces [48]. In a study based on [Ca2+]i measurements, when NCX was arrested by removing both external Na+ and Ca2+, Ca2+ released from the SER was resequestered. However, when both NCX and SERCA were blocked, the Ca2+ released from the SER was extruded from the cells by PMCA [27]. It has been suggested that localization of NCX in caveolae in conjunction with other Ca2+ transporters may lead to specialized regulation pockets [1, 2, 12, 13, 23, 25, 26, 27, 36, 40, 41, 42, 43, 49, 50].

Differences in NCX‐mediated Ca2+ uptake in EC and SMC

The NCX‐mediated Ca2+ uptake in EC was greater than in SMC with and without prior loading with BAPTA. This result is consistent with the previously reported higher levels of NCX expression in Western blots in EC than in SMC [16]. Phospholemman mRNA abundance is greater in SMC than in EC [16]. Phosphorylated phospholemman inhibits NCX but its role in SMC remains to be determined [20, 21]. Another interesting difference is that thapsigargin inhibited the NCX‐mediated Ca2+ entry in SMC but not in EC. A possible explanation for the lack of an effect of thapsigargin in EC is a very small SERCA to NCX activity ratio. The SERCA activity in EC is approximately one tenth of that in SMC and the NCX‐mediated Ca2+ entry was approximately five‐fold higher [16]. Therefore, the hypothesis of a functional NCX‐SERCA linkage is consistent with the observation that the effects of thapsigargin and BAPTA were minimal in EC. Furthermore, in SMC, most of the SERCA protein is SERCA2 while EC contain SERCA3 and some SERCA2. Whether or not the SERCA isoform difference plays a role in this functional linkage remains to be shown.

Physiological and pathophysiological implications

The NCX‐mediated 45Ca2+ uptake was used here as an experimental tool but it does occur in physiological situations. First, this mode of NCX may play a role in refilling the SER in smooth muscle [13, 25, 26, 27]. The NCX‐mediated Ca2+ uptake may also contribute to maintain a longer and stronger contraction. The NCX‐mediated Ca2+ uptake has also been found in pathological situations when ion distributions are deregulated [3, 19, 51, 52, 53]. A potentially harmful effect of NCX in this mode is the subsequent Ca2+ overloading in the cell. Inhibition of this entry by agents such as SEA 0400 and KB‐R7943 may be therapeutically useful [37]. In the coronary artery, Ca2+ deregulation can cause a dysfunction in coronary tone, and may lead to pathological states such as hypertension, ischaemia, and oxidative stress [54]. The difference in NCX activity between SMC and EC may be related to the unique Ca2+ handling requirements of the two cell types. In SMC, the tight [Ca2+]i regulation may be performed by low capacity high affinity transporters such as PMCA. Furthermore, SMC contain a large amount of SER and SERCA, the SER restricts the mobility of Ca2+ throughout the cell by sequestering large amounts of Ca2+. Therefore the presence of large PMCA and SERCA activity may replace the need for high capacity Ca2+ removal systems such as NCX. NCX‐SERCA linkage may also be damaged during pathophysiological states which may in turn, amplify the disturbance. SERCA2b is more susceptible to oxidative stress than SERCA3 [31, 47]. It remains to be demonstrated how this damage to SERCA2b affects NCX activity and/or the linkage between NCX and SERCA.

Evidence implicating the role of NCX‐SERCA functional linkage in endothelium is rare although it was found that NCX activity is involved in the NO‐induced depletion of Ca2+ in the SER [35, 55]. Thus, in some types of endothelial cells, the SER may have a functional NCX‐SERCA linkage. The NCX‐SERCA linkage may not be as important in coronary artery EC since the SERCA pump content is very small and present as two isoforms (SERCA3 and SERCA2). A different model based on a direct relationship between eNOS and NCX may be applicable in EC where high [Ca2+]i may stimulate NO synthesis. The removal of high [Ca2+]i by NCX can stop or decrease NO synthesis to aid in sustaining the coronary tension. The presence of NO can also stimulate NCX‐mediated Ca2+ extrusion through direct or indirect mechanisms, thus expelling more Ca2+ or the same amount of Ca2+ faster [56, 57]. This may be a feedback mechanism to decrease high levels of NO, especially under conditions of stress.

Acknowledgements

We thank Dr. P. K. Rangachari for his suggestions. This work was supported by a Grant‐in‐Aid (T6168) from the Heart & Stroke Foundation of Ontario.

References

  • 1. Clapham DE. Calcium signaling. Cell . 2007; 131: 1047–58. [DOI] [PubMed] [Google Scholar]
  • 2. Floyd R, Wray S. Calcium transporters and signalling in smooth muscles. Cell Calcium . 2007; 42: 467–76. [DOI] [PubMed] [Google Scholar]
  • 3. Annunziato L, Pignataro G, Boscia F, et al. Ncx1, ncx2, and ncx3 gene product expression and function in neuronal anoxia and brain ischemia. Ann NY Acad Sci . 2007; 1099: 413–26. [DOI] [PubMed] [Google Scholar]
  • 4. Philipson KD, Nicoll DA. Sodium‐calcium exchange: a molecular perspective. Annu Rev Physiol 2000; 62: 111–33. [DOI] [PubMed] [Google Scholar]
  • 5. Baba‐Aissa F, Raeymaekers L, Wuytack F, et al. Distribution and isoform diversity of the organellar Ca2+ pumps in the brain. Mol Chem Neuropathol . 1998; 33: 199–208. [DOI] [PubMed] [Google Scholar]
  • 6. Inesi G, Prasad AM, Pilankatta R. The Ca2+ ATPase of cardiac sarcoplasmic reticulum: physiological role and relevance to diseases. Biochem Biophys Res Commun . 2008; 369: 182–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Misquitta CM, Mack DP, Grover AK. Sarco/endoplasmic reticulum Ca2+ (SERCA)‐pumps: link to heart beats and calcium waves. Cell Calcium . 1999; 25: 277–90. [DOI] [PubMed] [Google Scholar]
  • 8. Lytton J, Westlin M, Burk SE, et al. Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J Biol Chem . 1992; 267: 14483–9. [PubMed] [Google Scholar]
  • 9. Strehler EE, Caride AJ, Filoteo AG, et al. Plasma membrane Ca2+ ATPases as dynamic regulators of cellular calcium handling. Ann NY Acad Sci . 2007; 1099: 226–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Pande J, Grover AK. Plasma membrane calcium pumps in smooth muscle: from fictional molecules to novel inhibitors. Can J Physiol Pharmacol . 2005; 83: 743–54. [DOI] [PubMed] [Google Scholar]
  • 11. Di Leva F, Domi T, Fedrizzi L, et al. The plasma membrane Ca(2+) ATPase of animal cells: structure, function and regulation. Arch Biochem Biophys . 2008; 476: 65–74. [DOI] [PubMed] [Google Scholar]
  • 12. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev . 1999; 79: 763–854. [DOI] [PubMed] [Google Scholar]
  • 13. Fameli N, van Breemen C, Kuo KH. A quantitative model for linking Na+/Ca2+ exchanger to SERCA during refilling of the sarcoplasmic reticulum to sustain [Ca2+] oscillations in vascular smooth muscle. Cell Calcium . 2007; 42: 565–75. [DOI] [PubMed] [Google Scholar]
  • 14. Lytton J, Li XF, Dong H, et al. K+‐dependent Na+/Ca2+ exchangers in the brain. Ann NY Acad Sci . 2002; 976: 382–93. [DOI] [PubMed] [Google Scholar]
  • 15. Lytton J. Na+/Ca2+ exchangers: three mammalian gene families control Ca2+ transport. Biochem J . 2007; 406: 365–82. [DOI] [PubMed] [Google Scholar]
  • 16. Szewczyk MM, Davis KA, Samson SE, et al. Ca2+‐pumps and Na2+‐Ca2+‐exchangers in coronary artery endothelium versus smooth muscle. J Cell Mol Med . 2007; 11: 129–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Pande J, Mallhi KK, Sawh A, et al. Aortic smooth muscle and endothelial plasma membrane Ca2+ pump isoforms are inhibited differently by the extracellular inhibitor caloxin 1b1. Am J Physiol Cell Physiol . 2006; 290: C1341–9. [DOI] [PubMed] [Google Scholar]
  • 18. Khan I, Sandhu V, Misquitta CM, et al. SERCA pump isoform expression in endothelium of veins and arteries: every endothelium is not the same. Mol Cell Biochem . 2000; 203: 11–5. [DOI] [PubMed] [Google Scholar]
  • 19. Bers DM, Despa S, Bossuyt J. Regulation of Ca2+ and Na+ in normal and failing cardiac myocytes. Ann NY Acad Sci . 2006; 1080: 165–77. [DOI] [PubMed] [Google Scholar]
  • 20. Zhang XQ, Ahlers BA, Tucker AL, et al. Phospholemman inhibition of the cardiac Na+/Ca2+ exchanger: role of phosphorylation. J Biol Chem . 2006; 281: 7784–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Zhang XQ, Qureshi A, Song J, et al. Phospholemman modulates Na+/Ca2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol . 2003; 284: H225–33. [DOI] [PubMed] [Google Scholar]
  • 22. Cheung JY, Rothblum LI, Moorman JR, et al. Regulation of cardiac Na+/Ca2+ exchanger by phospholemman. Ann NY Acad Sci . 2007; 1099: 119–34. [DOI] [PubMed] [Google Scholar]
  • 23. Daniel EE, El Yazbi A, Cho WJ. Caveolae and calcium handling, a review and a hypothesis. J Cell Mol Med . 2006; 10: 529–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. El Yazbi AF, Cho WJ, Cena J, et al. Smooth muscle NOS, co‐localized with caveolin‐1, modulates contraction in mouse small intestine. J Cell Mol Med . 2008; 12: 1404–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. van Breemen C, Chen Q, Laher I. Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum. Trends Pharmacol Sci . 1995; 16: 98–105. [DOI] [PubMed] [Google Scholar]
  • 26. Lee CH, Poburko D, Sahota P, et al. The mechanism of phenylephrine‐mediated [Ca(2+)](i) oscillations underlying tonic contraction in the rabbit inferior vena cava. J Physiol . 2001; 534: 641–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Nazer MA, van Breemen C. Functional linkage of Na(+)‐Ca2+ exchange and sarcoplasmic reticulum Ca2+ release mediates Ca2+ cycling in vascular smooth muscle. Cell Calcium . 1998; 24: 275–83. [DOI] [PubMed] [Google Scholar]
  • 28. Bova S, Goldman WF, Yauan XJ, et al. Influence of Na+ gradient on Ca2+ transients and contraction in vascular smooth muscle. Am J Physiol . 1990; 259: H409–23. [DOI] [PubMed] [Google Scholar]
  • 29. Schweda F, Seebauer H, Kramer BK, et al. Functional role of sodium‐calcium exchange in the regulation of renal vascular resistance. Am J Physiol Renal Physiol . 2001; 280: F155–61. [DOI] [PubMed] [Google Scholar]
  • 30. Slodzinski MK, Blaustein MP. Physiological effects of Na+/Ca2+ exchanger knockdown by antisense oligodeoxynucleotides in arterial myocytes. Am J Physiol . 1998; 275: C251–9. [DOI] [PubMed] [Google Scholar]
  • 31. Grover AK, Samson SE. Peroxide resistance of ER Ca2+ pump in endothelium: implications to coronary artery function. Am J Physiol .1997; 273: C1250–8. [DOI] [PubMed] [Google Scholar]
  • 32. Grover AK, Samson SE, Lee RM. Subcellular fractionation of pig coronary artery smooth muscle. Biochim Biophys Acta . 1985; 818: 191–9. [DOI] [PubMed] [Google Scholar]
  • 33. Sepulveda MR, Berrocal‐Carrillo M, Gasset M, et al. The plasma membrane Ca2+‐ATPase isoform 4 is localized in lipid rafts of cerebellum synaptic plasma membranes. J Biol Chem . 2006; 281: 447–53. [DOI] [PubMed] [Google Scholar]
  • 34. Davis KA, Samson SE, Best K, et al. Ca2+‐mediated ascorbate release from coronary artery endothelial cells. Br J Pharmacol . 2006; 147: 131–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Teubl M, Groschner K, Kohlwein SD, et al. Na(+)/Ca(2+) exchange facilitates Ca(2+)‐dependent activation of endothelial nitric‐oxide synthase. J Biol Chem . 1999; 274: 29529–35. [DOI] [PubMed] [Google Scholar]
  • 36. Poburko D, Liao CH, Lemos VS, et al. Transient receptor potential channel 6‐mediated, localized cytosolic [Na+] transients drive Na+/Ca2+ exchanger‐mediated Ca2+ entry in purinergically stimulated aorta smooth muscle cells. Circ Res . 2007; 101: 1030–8. [DOI] [PubMed] [Google Scholar]
  • 37. Iwamoto T. Forefront of Na+/Ca2+ exchanger studies: molecular pharmacology of Na+/Ca2+ exchange inhibitors. J Pharmacol Sci . 2004; 96: 27–32. [DOI] [PubMed] [Google Scholar]
  • 38. Iwamoto T, Watano T, Shigekawa M. A novel isothiourea derivative selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing NCX1. J Biol Chem . 1996; 271: 22391–7. [DOI] [PubMed] [Google Scholar]
  • 39. Birinyi P, Acsai K, Banyasz T, et al. Effects of SEA0400 and KB‐R7943 on Na+/Ca2+ exchange current and L‐type Ca2+ current in canine ventricular cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol . 2005; 372: 63–70. [DOI] [PubMed] [Google Scholar]
  • 40. Cho WJ, Daniel EE. Colocalization between caveolin isoforms in the intestinal smooth muscle and interstitial cells of Cajal of the Cav1(+/+) and Cav1 (−/−) mouse. Histochem Cell Biol . 2006; 126: 9–16. [DOI] [PubMed] [Google Scholar]
  • 41. Gherghiceanu M, Popescu LM. Electron microscope tomography: further demonstration of nanocontacts between caveolae and smooth muscle sarcoplasmic reticulum. J Cell Mol Med . 2007; 11: 1416–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Gherghiceanu M, Popescu LM. Caveolar nanospaces in smooth muscle cells. J Cell Mol Med . 2006; 10: 519–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Darby PJ, Kwan CY, Daniel EE. Caveolae from canine airway smooth muscle contain the necessary components for a role in Ca(2+) handling. Am J Physiol Lung Cell Mol Physiol . 2000; 279: L1226–35. [DOI] [PubMed] [Google Scholar]
  • 44. Cavalli A, Eghbali M, Minosyan TY, et al. Localization of sarcolemmal proteins to lipid rafts in the myocardium. Cell Calcium . 2007; 42: 313–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Lisanti MP, Scherer PE, Vidugiriene J, et al. Characterization of caveolin‐rich membrane domains isolated from an endothelial‐rich source: implications for human disease. J Cell Biol . 1994; 126: 111–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Silva WI, Maldonado HM, Lisanti MP, et al. Identification of caveolae and caveolin in C6 glioma cells. Int J Dev Neurosci . 1999; 17: 705–14. [DOI] [PubMed] [Google Scholar]
  • 47. Grover AK, Kwan CY, Samson SE. Effects of peroxynitrite on sarco/endoplasmic reticulum Ca2+ pump isoforms SERCA2b and SERCA3a. Am J Physiol Cell Physiol . 2003; 285: C1537–43. [DOI] [PubMed] [Google Scholar]
  • 48. Lencesova L, O’Neill A, Resneck WG, et al. Plasma membrane‐cytoskeleton‐endoplasmic reticulum complexes in neurons and astrocytes. J Biol Chem . 2004; 279: 2885–93. [DOI] [PubMed] [Google Scholar]
  • 49. Bossuyt J, Taylor BE, James‐Kracke M, et al. The cardiac sodium‐calcium exchanger associates with caveolin‐3. Ann NY Acad Sci . 2002; 976: 197–204. [DOI] [PubMed] [Google Scholar]
  • 50. Bossuyt J, Taylor BE, James‐Kracke M, et al. Evidence for cardiac sodium‐calcium exchanger association with caveolin‐3. FEBS Lett . 2002; 511: 113–7. [DOI] [PubMed] [Google Scholar]
  • 51. Zhang S, Dong H, Rubin LJ, et al. Upregulation of Na+/Ca2+ exchanger contributes to the enhanced Ca2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Am J Physiol Cell Physiol . 2007; 292: C2297–305. [DOI] [PubMed] [Google Scholar]
  • 52. Iwamoto T, Kita S. Hypertension, Na+/Ca2+ exchanger, and Na+, K+‐ATPase. Kidney Int . 2006; 69: 2148–54. [DOI] [PubMed] [Google Scholar]
  • 53. Munch G, Rosport K, Baumgartner C, et al. Functional alterations after cardiac sodium‐calcium exchanger overexpression in heart failure. Am J Physiol Heart Circ Physiol . 2006; 291: H488–95. [DOI] [PubMed] [Google Scholar]
  • 54. Walia M, Kwan CY, Grover AK. Effects of free radicals on coronary artery. Med Princ Pract . 2003; 12: 1–9. [DOI] [PubMed] [Google Scholar]
  • 55. Schneider JC, El Kebir D, Chereau C, et al. Involvement of Na(+)/Ca(2+) exchanger in endothelial NO production and endothelium‐dependent relaxation. Am J Physiol Heart Circ Physiol . 2002; 283: H837–44. [DOI] [PubMed] [Google Scholar]
  • 56. Amoroso S, Tortiglione A, Secondo A, et al. Sodium nitroprusside prevents chemical hypoxia‐induced cell death through iron ions stimulating the activity of the Na+‐Ca2+ exchanger in C6 glioma cells. J Neurochem . 2000; 74: 1505–13. [DOI] [PubMed] [Google Scholar]
  • 57. Schulz R, Triggle CR. Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol Sci . 1994; 15: 255–9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES